Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation.


Journal

Experimental hematology
ISSN: 1873-2399
Titre abrégé: Exp Hematol
Pays: Netherlands
ID NLM: 0402313

Informations de publication

Date de publication:
04 2022
Historique:
received: 13 09 2021
revised: 02 01 2022
accepted: 08 01 2022
pubmed: 17 1 2022
medline: 6 4 2022
entrez: 16 1 2022
Statut: ppublish

Résumé

Acute graft-versus-host-disease (aGVHD) is the main cause of morbidity and nonrelapse mortality (NRM) following allogeneic hematopoietic cell transplantation (alloHCT). Nausea, vomiting, and anorexia after alloHCT can be early signs of aGVHD of the gastrointestinal tract (GIT) but may also reflect lasting mucosal damage or side effects of drugs. If upper GIT aGVHD is suspected, upper endoscopic evaluation and histological examination are crucial. Still, the interpretation of clinical symptoms, macroscopical alterations, and histological findings can be challenging. Therefore, we conducted a retrospective analysis on single-center data from 174 patients with suspected aGVHD of the upper GIT who underwent upper endoscopy within the first 6 weeks after alloHCT, to study the distribution of aGVHD-related histological findings in relation to clinical symptoms and macroscopic findings and to correlate the severity of changes with data on relapse and NRM. Our data suggest that biopsies of the duodenum reveal the severity of upper GIT aGVHD most accurately. While the histological grading correlated weakly with the severity of macroscopic changes, we found a tight correlation between histological and clinical grades of upper GIT aGVHD (p < 0.001). Although correlation of histological grading of upper GIT aGVHD with the risk for NRM missed statistical significance (HR 1.53, Lerner ≥1° versus <1º, p = 0.13), overall clinical aGVHD severity correlated with NRM (HR 4.3, IIIº-IVº versus 0-Iº, p < 0.01). In conclusion, biopsies from the duodenum are most sensitive in excluding aGVHD in patients with normal macroscopic findings at esophagogastroduodenoscopy. Clinical grading of aGVHD predicts NRM better than histological grading.

Identifiants

pubmed: 35033627
pii: S0301-472X(22)00033-9
doi: 10.1016/j.exphem.2022.01.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-45

Informations de copyright

Copyright © 2022 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest disclosure The authors declare no conflicts of interest.

Auteurs

Abed A Sarraf (AA)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany. Electronic address: abed.sarraf@uniklinikum-dresden.de.

Johannes Schetelig (J)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany; Clinical Trials Unit, German Bone Marrow Donor Center (DKMS), Dresden, Germany.

Henning Baldauf (H)

Clinical Trials Unit, German Bone Marrow Donor Center (DKMS), Dresden, Germany.

Friedrich Stölzel (F)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany; Clinical Trials Unit, German Bone Marrow Donor Center (DKMS), Dresden, Germany.

Jan Moritz Middeke (JM)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Katja Sockel (K)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Raphael Teipel (R)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Stefan Brückner (S)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Marco Berning (M)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Sebastian Zeissig (S)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Jana Babatz (J)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Gustavo B Baretton (GB)

Institute of Pathology, Faculty of Medicine and University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jochen Hampe (J)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Martin Bornhäuser (M)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany.

Daniela Aust (D)

Institute of Pathology, Faculty of Medicine and University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Renate Schmelz (R)

Department of Internal Medicine I, University Hospital "Carl Gustav Carus," TU Dresden, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH